Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 AGE-RAGE signaling pathway in diabetic complications 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
2 AGE-RAGE signaling pathway in diabetic complications 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
3 AGE-RAGE signaling pathway in diabetic complications 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
4 AGE-RAGE signaling pathway in diabetic complications 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
5 Alzheimer disease 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
6 Alzheimer disease 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
7 Alzheimer disease 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
8 Alzheimer disease 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
9 Cellular senescence 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
10 Cellular senescence 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
11 Cellular senescence 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
12 Cellular senescence 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
13 Cytokine-cytokine receptor interaction 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
14 Cytokine-cytokine receptor interaction 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
15 Cytokine-cytokine receptor interaction 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
16 Cytokine-cytokine receptor interaction 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
17 Fluid shear stress and atherosclerosis 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
18 Fluid shear stress and atherosclerosis 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
19 Fluid shear stress and atherosclerosis 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
20 Fluid shear stress and atherosclerosis 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
21 Graft-versus-host disease 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
22 Graft-versus-host disease 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
23 Graft-versus-host disease 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
24 Graft-versus-host disease 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
25 Hematopoietic cell lineage 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
26 Hematopoietic cell lineage 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
27 Hematopoietic cell lineage 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
28 Hematopoietic cell lineage 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
29 Inflammatory bowel disease 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
30 Inflammatory bowel disease 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
31 Inflammatory bowel disease 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
32 Inflammatory bowel disease 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
33 Influenza A 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
34 Influenza A 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
35 Influenza A 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
36 Influenza A 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
37 Leishmaniasis 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
38 Leishmaniasis 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
39 Leishmaniasis 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
40 Leishmaniasis 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
41 MAPK signaling pathway 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
42 MAPK signaling pathway 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
43 MAPK signaling pathway 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
44 MAPK signaling pathway 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
45 Measles 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
46 Measles 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
47 Measles 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
48 Measles 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
49 Necroptosis 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
50 Necroptosis 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
51 Necroptosis 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
52 Necroptosis 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
53 Non-alcoholic fatty liver disease 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
54 Non-alcoholic fatty liver disease 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
55 Non-alcoholic fatty liver disease 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
56 Non-alcoholic fatty liver disease 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
57 Osteoclast differentiation 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
58 Osteoclast differentiation 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
59 Osteoclast differentiation 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
60 Osteoclast differentiation 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
61 Pathways of neurodegeneration - multiple diseases 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
62 Pathways of neurodegeneration - multiple diseases 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
63 Pathways of neurodegeneration - multiple diseases 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
64 Pathways of neurodegeneration - multiple diseases 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
65 Pertussis 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
66 Pertussis 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
67 Pertussis 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
68 Pertussis 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
69 Prion disease 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
70 Prion disease 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
71 Prion disease 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
72 Prion disease 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
73 Rheumatoid arthritis 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
74 Rheumatoid arthritis 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
75 Rheumatoid arthritis 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
76 Rheumatoid arthritis 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
77 Tuberculosis 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
78 Tuberculosis 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
79 Tuberculosis 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
80 Tuberculosis 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬
81 Type I diabetes mellitus 💬
1件: IL1A 💬 Bermekimab 💬 Bermekimab 1件: 51 💬
82 Type I diabetes mellitus 💬
1件: IL1A 💬 Lutikizumab 💬 Lutikizumab 3件: 46, 96, 97 💬
83 Type I diabetes mellitus 💬
1件: IL1A 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
84 Type I diabetes mellitus 💬
1件: IL1A 💬 Rilonacept 💬 Rilonacept 5件: 51, 84, 106, 107, 266 💬